A California federal judge has denied SomaLogic’s request to dismiss a case brought by a former employee who argues he’s owed unvested stock.
The case traces back to Ashwin Gopinath, the co-founder of a company bought by SomaLogic in 2022. Gopinath joined SomaLogic as a senior director of assay development, securing a pay package that included more than $1.6 million in cash and more than 76,000 shares of the biotech’s stock. His total stock compensation of 450,000-plus shares would vest over several years if he remained employed, according to court documents.
However, Gopinath left the company earlier this year, naming a number of reasons — including that the company ignored his concerns and gave unreasonable demands. While SomaLogic argues that Gopinath shouldn’t be entitled to his unvested stock or milestones, Gopinath claims he resigned…
Click here to view original post
